82 FR 60199 - Agency Forms Undergoing Paperwork Reduction Act Review
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 82, Issue 242 (December 19, 2017)
Centers for Disease Control and Prevention
Federal Register Volume 82, Issue 242 (December 19, 2017)
| Page Range | 60199-60200 | |
| FR Document | 2017-27257 |
[Federal Register Volume 82, Number 242 (Tuesday, December 19, 2017)] [Notices] [Pages 60199-60200] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-27257] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day-18-17AMP] Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled Evaluation of the SAMHSA Naloxone Education and Distribution Program to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ``Proposed Data Collection Submitted for Public Comment and Recommendations'' notice on July 17, 2017 to obtain comments from the public and affected agencies. CDC did not receive comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639-7570 or send an email to omb@cdc.gov. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide written comments within 30 days of notice publication. Proposed Project Evaluation of the SAMHSA Naloxone Education and Distribution Program--New--National Center for Injury Prevention and Control (NCIPC), Centers for Disease Control and Prevention (CDC). Background and Brief Description Overdose deaths involving prescription opioids and heroin have reached epidemic levels in the U.S. and continue to rise. To address the prescription drug/opioid overdose crisis, the federal government has recently allocated funding to improve access to treatment for opioid use disorders, reduce opioid related deaths, and strengthen prevention efforts. One program resulting from the federal government's efforts to address the opioid crisis is the Substance Abuse and Mental Health Services Agency (SAMHSA) Grants to Prevent Prescription Drug/ Opioid Overdose-Related Deaths. This proposed information collection project will help evaluate this program. Through this program, SAMHSA awarded funding to 12 states. The funding is aimed at reducing the number of prescription drug/opioid overdose-related deaths and adverse events among individuals 18 years of [[Page 60200]] age and older through educating and training first responders and other key community sectors on the prevention of prescription drug/opioid overdose-related deaths, including the purchase and distribution of naloxone. SAMHSA is funding the grant and CDC is responsible for conducting the grantee evaluation. The intended use of the resulting data is to increase CDC and SAMHSA understanding of the scope and impact of the program on overdose fatalities and how program effectiveness may vary among different sub- populations and settings, and to increase knowledge of barriers and facilitators to program implementation. Researchers will use key informant interviews and focus groups with participants in the activities enacted by the twelve state grant recipients. Participants will include state administrators of the grant and other PDO/Naloxone stakeholders including advisory council members, first responders, social service providers, laypersons including end users and their family and friend. All focus groups and interviews will be analyzed through qualitative content analysis, including utilization of a systematic coding scheme. Total burden in hours for this collection is 381. There are no costs to respondents other than their time. CDC requests a three-year OMB approval to collect the necessary project-related information. Estimated Annualized Burden Hours ---------------------------------------------------------------------------------------------------------------- Number of Average burden Type of respondents Form name Number of responses per per response respondents respondent (in hours) ---------------------------------------------------------------------------------------------------------------- PDO/Naloxone Advisory Committee Focus Group Discussion 140 1 1.5 Members and Grantees. Guide. PDO/Naloxone Grantees................. Key Informant Interview 36 1 1 Guide for Grantees. PDO/Naloxone Stakeholders and Partners Key Informant Interview 84 1 1 Guide for Partners. PDO/Naloxone Laypersons............... Key Informant Interview 24 1 1 Guide for Laypersons. All participants (PDO Naloxone Recruitment contact 284 1 5/60 grantees, advisory committee, script. stakeholders and partners, laypersons). PDO/Naloxone Grantees................. Key Informant Selection 12 1 15/60 Tool. ---------------------------------------------------------------------------------------------------------------- Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2017-27257 Filed 12-18-17; 8:45 am] BILLING CODE 4163-18-P
![Federal Register / Vol. 82, No. 242 / Tuesday, December 19, 2017 / Notices 60199
Assisted Living, American Seniors Expected burden from data collection an eligibility rate for ADSCs of 86% and
Housing Association, Argentum for eligible cases is 80 minutes per for RCCs of 76%. One-year clearance
(formerly Assisted Living Federation of respondent: 5 minutes for a contact requested to cover the collection of data.
America), National Adult Day Services confirmation call; 15 minutes for a The burden for the collection shown in
Association; universities; foundations; screener and appointment setting call; Table 1 below. There is no cost to
and other private sector organizations 30 minutes for a provider questionnaire; respondents other than their time to
such as the Alzheimer’s Association and and 30 minutes for a sampling and participate.
the AARP Public Policy Institute. services user questionnaire. We estimate
ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per Total burden
Type of respondents Form name responses per
respondents response (in hours)
respondent (in hours)
RCC/ADSC Director/Designated Contact Confirmation Call ................ 3,740 1 5/60 312
Staff Member.
RCC/ADSC Director/Designated Screener and Appointment Setting 3,740 1 15/60 935
Staff Member. Call.
RCC Director/Designated Staff Mem- RCC Provider Questionnaire ........... 1,589 1 30/60 795
ber.
ADSC Director/Designated Staff ADSC Provider Questionnaire ......... 1,419 1 30/60 710
Member.
RCC Director/Designated Staff Mem- RCC Sampling and Services User 1,589 1 30/60 795
ber. Questionnaire.
ADSC Director/Designated Staff ADSC Sampling and Services User 1,419 1 30/60 710
Member. Questionnaire.
Total ........................................... ........................................................... ........................ ........................ ........................ 4,257
Leroy A. Richardson, CDC will accept all comments for this Budget, 725 17th Street NW,
Chief, Information Collection Review Office, proposed information collection project. Washington, DC 20503 or by fax to (202)
Office of Scientific Integrity, Office of the The Office of Management and Budget 395–5806. Provide written comments
Associate Director for Science, Office of the is particularly interested in comments within 30 days of notice publication.
Director, Centers for Disease Control and that:
Prevention. (a) Evaluate whether the proposed Proposed Project
[FR Doc. 2017–27258 Filed 12–18–17; 8:45 am] collection of information is necessary Evaluation of the SAMHSA Naloxone
BILLING CODE 4163–18–P for the proper performance of the Education and Distribution Program—
functions of the agency, including New—National Center for Injury
whether the information will have Prevention and Control (NCIPC),
DEPARTMENT OF HEALTH AND practical utility; Centers for Disease Control and
HUMAN SERVICES (b) Evaluate the accuracy of the Prevention (CDC).
agencies estimate of the burden of the Background and Brief Description
Centers for Disease Control and proposed collection of information,
Prevention including the validity of the Overdose deaths involving
methodology and assumptions used; prescription opioids and heroin have
[30Day–18–17AMP] (c) Enhance the quality, utility, and reached epidemic levels in the U.S. and
clarity of the information to be continue to rise. To address the
Agency Forms Undergoing Paperwork collected; prescription drug/opioid overdose
Reduction Act Review (d) Minimize the burden of the crisis, the federal government has
collection of information on those who recently allocated funding to improve
In accordance with the Paperwork are to respond, including, through the access to treatment for opioid use
Reduction Act of 1995, the Centers for use of appropriate automated, disorders, reduce opioid related deaths,
Disease Control and Prevention (CDC) electronic, mechanical, or other and strengthen prevention efforts. One
has submitted the information technological collection techniques or program resulting from the federal
collection request titled Evaluation of other forms of information technology, government’s efforts to address the
the SAMHSA Naloxone Education and e.g., permitting electronic submission of opioid crisis is the Substance Abuse and
Distribution Program to the Office of responses; and Mental Health Services Agency
Management and Budget (OMB) for (e) Assess information collection (SAMHSA) Grants to Prevent
review and approval. CDC previously costs. Prescription Drug/Opioid Overdose-
published a ‘‘Proposed Data Collection To request additional information on Related Deaths. This proposed
Submitted for Public Comment and the proposed project or to obtain a copy
sradovich on DSK3GMQ082PROD with NOTICES
information collection project will help
Recommendations’’ notice on July 17, of the information collection plan and evaluate this program.
2017 to obtain comments from the instruments, call (404) 639–7570 or Through this program, SAMHSA
public and affected agencies. CDC did send an email to omb@cdc.gov. Direct awarded funding to 12 states. The
not receive comments related to the written comments and/or suggestions funding is aimed at reducing the
previous notice. This notice serves to regarding the items contained in this number of prescription drug/opioid
allow an additional 30 days for public notice to the Attention: CDC Desk overdose-related deaths and adverse
and affected agency comments. Officer, Office of Management and events among individuals 18 years of
VerDate Sep<11>2014 17:47 Dec 18, 2017 Jkt 244001 PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 E:\FR\FM\19DEN1.SGM 19DEN1](https://thefederalregister.org/doc/82_FR_60441/page/1.svg)
![60200 Federal Register / Vol. 82, No. 242 / Tuesday, December 19, 2017 / Notices
age and older through educating and and how program effectiveness may responders, social service providers,
training first responders and other key vary among different sub-populations laypersons including end users and
community sectors on the prevention of and settings, and to increase knowledge their family and friend. All focus groups
prescription drug/opioid overdose- of barriers and facilitators to program and interviews will be analyzed through
related deaths, including the purchase implementation. qualitative content analysis, including
and distribution of naloxone. SAMHSA Researchers will use key informant utilization of a systematic coding
is funding the grant and CDC is interviews and focus groups with scheme.
responsible for conducting the grantee participants in the activities enacted by Total burden in hours for this
evaluation. the twelve state grant recipients. collection is 381. There are no costs to
The intended use of the resulting data Participants will include state respondents other than their time. CDC
is to increase CDC and SAMHSA administrators of the grant and other requests a three-year OMB approval to
understanding of the scope and impact PDO/Naloxone stakeholders including collect the necessary project-related
of the program on overdose fatalities advisory council members, first information.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per
Type of respondents Form name responses per
respondents response
respondent (in hours)
PDO/Naloxone Advisory Committee Members Focus Group Discussion Guide ..................... 140 1 1.5
and Grantees.
PDO/Naloxone Grantees ................................ Key Informant Interview Guide for Grantees 36 1 1
PDO/Naloxone Stakeholders and Partners .... Key Informant Interview Guide for Partners .. 84 1 1
PDO/Naloxone Laypersons ............................ Key Informant Interview Guide for 24 1 1
Laypersons.
All participants (PDO Naloxone grantees, ad- Recruitment contact script ............................. 284 1 5/60
visory committee, stakeholders and part-
ners, laypersons).
PDO/Naloxone Grantees ................................ Key Informant Selection Tool ......................... 12 1 15/60
Leroy A. Richardson, DEPARTMENT OF HEALTH AND for a generic clearance to be used for the
Chief, Information Collection Review Office, HUMAN SERVICES financial reports used in the
Office of Scientific Integrity, Office of the administration of mandatory grants.
Associate Director for Science, Office of the Administration for Children and This clearance supports the
Director, Centers for Disease Control and Families Departments initiative of Generating
Prevention. Efficiencies through Streamlined
[FR Doc. 2017–27257 Filed 12–18–17; 8:45 am] Proposed Information Collection
Activity; Comment Request Processes by employing an abbreviated
BILLING CODE 4163–18–P process.
Proposed Projects If approved program offices will be at
Title: ACF Generic Clearance for liberty to tailor a financial report to their
Mandatory Grant Financial Reports. specific needs rather than adhering to a
OMB No.: 0970—New. standard form.
Description: OMB has granted
permission for ACF to submit a request Respondents: States and Territories.
ANNUAL BURDEN ESTIMATES
Number of Average
Number of Total burden
Instrument responses per burden hours
respondents hours
respondent per response
Mandatory Grant Financial Reports ................................................................. 900 4 5 18,000
Estimated Total Annual Burden Families, Office of Planning, Research practical utility; (b) the accuracy of the
Hours: and Evaluation, 330 C Street SW, agency’s estimate of the burden of the
In compliance with the requirements Washington, DC 20201. Attn: ACF proposed collection of information; (c)
of the Paperwork Reduction Act of 1995 Reports Clearance Officer. Email the quality, utility, and clarity of the
(Pub. L. 104–13, 44 U.S.C. Chap. 35), the address: infocollection@acf.hhs.gov. All information to be collected; and (d)
Administration for Children and requests should be identified by the title ways to minimize the burden of the
sradovich on DSK3GMQ082PROD with NOTICES
Families is soliciting public comment of the information collection. collection of information on
on the specific aspects of the The Department specifically requests respondents, including through the use
information collection described above. comments on: (a) Whether the proposed of automated collection techniques or
Copies of the proposed collection of collection of information is necessary other forms of information technology.
information can be obtained and for the proper performance of the Consideration will be given to
comments may be forwarded by writing functions of the agency, including
to the Administration for Children and whether the information shall have
VerDate Sep<11>2014 17:47 Dec 18, 2017 Jkt 244001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\19DEN1.SGM 19DEN1](https://thefederalregister.org/doc/82_FR_60441/page/2.svg)
Document Created: 2017-12-19 01:31:04
Document Modified: 2017-12-19 01:31:04
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 82 FR 60199 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR